Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P20823 (HNF1A_HUMAN)

Last modified November 25, 2008. Version 115. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Hepatocyte nuclear factor 1-alpha
      Short name=HNF-1A
Alternative name(s):
    Liver-specific transcription factor LF-B1
      Short name=LFB1
      Short name=Transcription factor 1
      Short name=TCF-1
Gene names
Name: HNF1A
Synonyms: TCF1
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length631 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Required for the expression of several liver specific genes. Binds to the inverted palindrome 5'-GTTAATNATTAAC-3'.

Subunit structure

Binds DNA as a dimer.

Subcellular location

Nucleus.

Tissue specificity

Liver.

Polymorphism

The Ala-98/Val-98 polymorphism is associated with a reduction in glucose-induced serum C-peptide and insulin responses.

Involvement in disease

Defects in HNF1A may predispose to hepatic adenomas [MIM:142330]. Hepatic adenomas are benign tumors at risk of malignant transformation. Bi-allelic inactivation of HNF1A, whether sporadic or associated with MODY3, may be an early step in the developmant of some hepatocellular carcinomas.

Defects in HNF1A are the cause of maturity onset diabetes of the young type 3 (MODY3) [MIM:600496]; also symbolized MODY-3. MODY [MIM:606391] is a form of diabetes characterized by an autosomal dominant mode of inheritance, age of onset of 25 years or younger and a primary defect in insulin secretion. The clinical phenotype of MODY3 is characterized by severe insulin secretory defects, and by major hyperglycemia associated with microvascular complications.

Defects in HNF1A are a cause of susceptibility to insulin-dependent diabetes mellitus (IDDM) [MIM:222100].

Sequence similarities

Belongs to the HNF1 homeobox family.

Contains 1 homeobox DNA-binding domain.

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform A (identifier: P20823-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform B (identifier: P20823-2)

The sequence of this isoform differs from the canonical sequence as follows:
     501-542: ALYSHKPEVA...LASLTPTKQV → GEHPVPHTAG...ACVSGTSVFP
     543-601: Missing.
Isoform C (identifier: P20823-3)

The sequence of this isoform differs from the canonical sequence as follows:
     438-494: LASTQAQSVP...TQSPFMATMA → KLVGMGGHLG...SHCATSVIPG
     495-601: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 631631Hepatocyte nuclear factor 1-alpha
PRO_0000049115

Regions

DNA binding199 – 27981Homeobox; HNF1-type
Region1 – 3131Dimerization
Motif197 – 2059Nuclear localization signal Potential
Compositional bias71 – 8010Asp/Glu-rich (acidic; potential involvement with transcription)

Amino acid modifications

Modified residue741Phosphothreonine By similarity
Modified residue2471Phosphoserine By similarity

Natural variations

Alternative sequence438 – 49457LASTQ…MATMA → KLVGMGGHLGGRLMGQPQNP GAGRATGTHSFIHSFIQHVF IQCLLWTSHCATSVIPG in isoform C.
VSP_002252
Alternative sequence495 – 601107Missing in isoform C.
VSP_002253
Alternative sequence501 – 54242ALYSH…PTKQV → GEHPVPHTAGDDDRGWLSMD AGERGAWQALQSACVSGTSV FP in isoform B.
VSP_002250
Alternative sequence543 – 60159Missing in isoform B.
VSP_002251
Natural variant121L → H in MODY3.
VAR_010537
Natural variant201G → R in MODY3.
VAR_012483
Natural variant271I → L: dbSNP rs1169288.
VAR_007905
Natural variant311G → D in MODY3.
VAR_010538
Natural variant481E → K in IDDM.
VAR_010539
Natural variant981A → V: dbSNP rs1800574.
VAR_010540
Natural variant1071L → R in MODY3.
VAR_010541
Natural variant1171K → E in MODY3.
VAR_010542
Natural variant1221Y → C in MODY3.
VAR_003756
Natural variant1271N → Y in a hepatocellular carcinoma sample; somatic mutation.
VAR_033088
Natural variant1281I → N in MODY3.
VAR_010543
Natural variant1291P → T in MODY3.
VAR_010544
Natural variant1311R → Q in MODY3.
VAR_010545
Natural variant1311R → W in MODY3.
VAR_010546
Natural variant1331V → M in MODY3.
VAR_010547
Natural variant1421S → F in MODY3.
VAR_003757
Natural variant1431H → Y in MODY3.
VAR_010548
Natural variant1581K → N in MODY3.
VAR_010549
Natural variant1591R → Q in MODY3.
VAR_003758
Natural variant1591R → W in MODY3.
VAR_010550
Natural variant1611A → T in MODY3.
VAR_010551
Natural variant1651W → C in a hepatocellular carcinoma sample; somatic mutation.
VAR_033089
Natural variant1911G → D in late-onset NIDDM.
VAR_010552
Natural variant2001R → W in MODY3.
VAR_010553
Natural variant2031R → C in MODY3.
VAR_010554
Natural variant2031R → H in MODY3.
VAR_012484
Natural variant2051K → Q in MODY3.
VAR_010555
Natural variant2061W → C in a hepatic adenoma sample; somatic mutation.
VAR_033090
Natural variant2061W → L in a hepatic adenoma sample; somatic mutation.
VAR_033091
Natural variant2291R → Q in MODY3.
VAR_010556
Natural variant2371N → S in a hepatic multiple adenoma sample; somatic mutation.
VAR_033092
Natural variant2411C → G in MODY3 and IDDM.
VAR_010557
Natural variant2441R → G in a hepatic adenoma sample; somatic mutation.
VAR_033093
Natural variant2501Q → P in a hepatocellular carcinoma sample; somatic mutation.
VAR_033094
Natural variant2541L → M in late-onset NIDDM; low penetrance; could be a rare polymorphism.
VAR_010558
Natural variant2591V → D in MODY3.
VAR_010559
Natural variant2601T → M in MODY3.
VAR_010560
Natural variant2631R → C in MODY3.
VAR_010561
Natural variant2681F → C in a hepatic adenoma sample; somatic mutation.
VAR_033095
Natural variant2711R → W in MODY3.
VAR_010562
Natural variant2721R → C in NIDDM.
VAR_010563
Natural variant2721R → H in IDDM and MODY3.
VAR_003759
Natural variant2731K → E in a hepatic adenoma sample; somatic mutation.
VAR_033096
Natural variant3191G → S Strong association with NIDDM susceptibility; unique to the Canadian Oji-Cree population.
VAR_010564
Natural variant4151G → R in IDDM; loss of function.
VAR_010565
Natural variant4321S → C in MODY3.
VAR_012485
Natural variant4471P → L in MODY3.
VAR_003760
Natural variant4871S → N: dbSNP rs2464196.
VAR_007906
Natural variant5141H → R
VAR_010566
Natural variant5191P → L in MODY3.
VAR_010567
Natural variant5371T → R in MODY3; incomplete penetrance.
VAR_010568
Natural variant5741G → S in a black African with an atypical form of diabetes; also in an individual with hepatic adenoma and familial early-onset diabetes. dbSNP rs1169305.
VAR_010569
Natural variant5831R → G in IDDM.
VAR_003761
Natural variant5831R → Q in late-onset NIDDM; also in an individual with hepatic hyperplasia and familial early-onset diabetes.
VAR_010570
Natural variant5941S → I in MODY3.
VAR_010571
Natural variant6181I → M in MODY3.
VAR_012486
Natural variant6191E → K in MODY3.
VAR_010572
Natural variant6201T → I in MODY3; incomplete penetrance.
VAR_010573

Secondary structure

...................... 631
Helix Strand Turn

Details...

Sequences

Sequence Length